Michelle M. Martinez-Montemayor
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reishi | 3 | 2019 | 10 | 1.340 |
Why?
|
| Antineoplastic Agents | 5 | 2019 | 1019 | 0.880 |
Why?
|
| 6-Phytase | 3 | 2008 | 3 | 0.730 |
Why?
|
| Zinc | 3 | 2008 | 131 | 0.660 |
Why?
|
| Cultural Diversity | 1 | 2021 | 193 | 0.600 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2019 | 26 | 0.590 |
Why?
|
| Biological Products | 1 | 2019 | 91 | 0.530 |
Why?
|
| Carrier Proteins | 1 | 2019 | 321 | 0.520 |
Why?
|
| Zingiberales | 1 | 2015 | 1 | 0.470 |
Why?
|
| Biomedical Research | 1 | 2021 | 502 | 0.460 |
Why?
|
| Minority Groups | 1 | 2021 | 690 | 0.460 |
Why?
|
| Membrane Proteins | 1 | 2019 | 561 | 0.460 |
Why?
|
| Cell Movement | 1 | 2019 | 655 | 0.450 |
Why?
|
| Metallothionein | 2 | 2005 | 20 | 0.440 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 184 | 0.400 |
Why?
|
| Blood Glucose | 1 | 2015 | 389 | 0.390 |
Why?
|
| Neoplasm Metastasis | 2 | 2011 | 237 | 0.370 |
Why?
|
| Dietary Supplements | 4 | 2012 | 213 | 0.370 |
Why?
|
| Plant Extracts | 1 | 2015 | 302 | 0.360 |
Why?
|
| Isoflavones | 2 | 2012 | 132 | 0.320 |
Why?
|
| Genistein | 1 | 2010 | 45 | 0.320 |
Why?
|
| Cell Line, Tumor | 8 | 2019 | 2676 | 0.310 |
Why?
|
| Liver | 3 | 2008 | 511 | 0.310 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 1723 | 0.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2012 | 968 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2019 | 63 | 0.260 |
Why?
|
| Blotting, Western | 3 | 2013 | 883 | 0.230 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 290 | 0.220 |
Why?
|
| Intestinal Mucosa | 1 | 2004 | 134 | 0.190 |
Why?
|
| Cell Survival | 2 | 2019 | 945 | 0.190 |
Why?
|
| Weaning | 3 | 2008 | 16 | 0.180 |
Why?
|
| Eukaryotic Initiation Factor-4G | 2 | 2012 | 14 | 0.180 |
Why?
|
| Swine | 3 | 2008 | 212 | 0.170 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 592 | 0.170 |
Why?
|
| RNA, Messenger | 2 | 2012 | 1271 | 0.170 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 561 | 0.170 |
Why?
|
| Mentors | 1 | 2021 | 145 | 0.150 |
Why?
|
| Ergosterol | 1 | 2019 | 12 | 0.150 |
Why?
|
| Pseudopodia | 1 | 2019 | 17 | 0.150 |
Why?
|
| Research Personnel | 1 | 2021 | 206 | 0.150 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 1070 | 0.140 |
Why?
|
| Fluorescent Dyes | 1 | 2019 | 182 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2019 | 456 | 0.130 |
Why?
|
| Animals | 8 | 2015 | 16992 | 0.130 |
Why?
|
| Humans | 9 | 2021 | 43102 | 0.130 |
Why?
|
| Female | 7 | 2019 | 24698 | 0.120 |
Why?
|
| Cladribine | 1 | 2015 | 3 | 0.120 |
Why?
|
| Guanosine | 1 | 2015 | 28 | 0.120 |
Why?
|
| Mice | 4 | 2015 | 6644 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 247 | 0.100 |
Why?
|
| Neoplasm Transplantation | 2 | 2012 | 129 | 0.100 |
Why?
|
| Mice, Nude | 2 | 2012 | 408 | 0.100 |
Why?
|
| Phytoestrogens | 1 | 2012 | 39 | 0.100 |
Why?
|
| DNA Primers | 1 | 2013 | 294 | 0.090 |
Why?
|
| Cell Proliferation | 3 | 2019 | 1455 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 132 | 0.090 |
Why?
|
| Kidney | 2 | 2005 | 372 | 0.090 |
Why?
|
| Catenins | 1 | 2011 | 5 | 0.090 |
Why?
|
| bcl-X Protein | 1 | 2011 | 27 | 0.090 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 76 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 196 | 0.090 |
Why?
|
| Base Sequence | 1 | 2013 | 983 | 0.080 |
Why?
|
| Cadherins | 1 | 2011 | 102 | 0.080 |
Why?
|
| Puerto Rico | 1 | 2015 | 1413 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 934 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 1869 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2019 | 2157 | 0.080 |
Why?
|
| Neoplasms | 1 | 2021 | 1377 | 0.080 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2009 | 22 | 0.070 |
Why?
|
| Catechin | 1 | 2009 | 39 | 0.070 |
Why?
|
| Expressed Sequence Tags | 1 | 2008 | 28 | 0.070 |
Why?
|
| Stilbenes | 1 | 2009 | 44 | 0.070 |
Why?
|
| Quercetin | 1 | 2009 | 46 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 652 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2009 | 49 | 0.070 |
Why?
|
| Vitis | 1 | 2009 | 37 | 0.070 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2009 | 69 | 0.070 |
Why?
|
| Disease Progression | 1 | 2010 | 667 | 0.070 |
Why?
|
| Spatial Behavior | 1 | 2006 | 22 | 0.060 |
Why?
|
| Discrimination Learning | 1 | 2006 | 38 | 0.060 |
Why?
|
| Exploratory Behavior | 1 | 2006 | 78 | 0.060 |
Why?
|
| Apoptosis | 2 | 2011 | 1568 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1542 | 0.060 |
Why?
|
| Jejunum | 1 | 2005 | 7 | 0.060 |
Why?
|
| Zinc Oxide | 1 | 2005 | 25 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 704 | 0.050 |
Why?
|
| Intestinal Absorption | 1 | 2004 | 22 | 0.050 |
Why?
|
| Copper | 1 | 2005 | 134 | 0.050 |
Why?
|
| Hippocampus | 1 | 2006 | 594 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2008 | 1003 | 0.050 |
Why?
|
| Male | 3 | 2015 | 23409 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2006 | 735 | 0.040 |
Why?
|
| Time Factors | 1 | 2005 | 1857 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2019 | 155 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 157 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2019 | 256 | 0.040 |
Why?
|
| Leukemia, Hairy Cell | 1 | 2015 | 3 | 0.030 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 11 | 0.030 |
Why?
|
| Lymphoma, T-Cell | 1 | 2015 | 29 | 0.030 |
Why?
|
| Organophosphorus Compounds | 1 | 2015 | 37 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 99 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 506 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 25 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2012 | 18 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 98 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 536 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2009 | 346 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2006 | 3 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2006 | 41 | 0.020 |
Why?
|
| Space Perception | 1 | 2006 | 35 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 113 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2006 | 108 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2009 | 358 | 0.020 |
Why?
|
| Extinction, Psychological | 1 | 2006 | 104 | 0.010 |
Why?
|
| Memory | 1 | 2006 | 174 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 575 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 3735 | 0.010 |
Why?
|